
    
      A phase I/II, open label, dose-escalation, multicenter, 12 month study designed to assess the
      safety and tolerability of catheter based percutaneous myocardial injection of VM202 in
      patients with chronic refractory myocardial ischemia. The study will consist of three (3)
      cohorts with a total of 4 subjects enrolled in each cohort. Endocardial injections will be
      performed with the MyoStar Injection Catheter under guidance of the NOGA XP Cardiac
      Navigation System.
    
  